Stock News
Categories
- All
- Editor's Picks
- Stock Analysis
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Crypto Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Tobacco Products
Altria Group Inc (MO) Q3 2024 Earnings Call Highlights: Strong EPS Growth Amid Market Challenges
Altria Group Inc (MO) reports a 7.8% increase in adjusted diluted EPS, while navigating market pressures and expanding its e-vapor and oral tobacco segments. Nov 01, 2024
Insurance
Allstate Corp (ALL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments
Allstate Corp (ALL) reports a 14.7% revenue increase and outlines strategies for growth amid challenges in customer retention and catastrophe losses. Nov 01, 2024
Drug Manufacturers
Merck & Co Inc (MRK) Q3 2024 Earnings Call Highlights: Strong Oncology and Animal Health Drive Revenue Growth
Despite challenges in GARDASIL sales, Merck & Co Inc (MRK) reports robust growth in KEYTRUDA and new product launches, setting a positive outlook for future quarters. Nov 01, 2024
Construction
Quanta Services Inc (PWR) Q3 2024 Earnings Call Highlights: Record Backlog and Strong Financial Performance Amid Supply Chain Challenges
Quanta Services Inc (PWR) reports robust growth in revenue and adjusted EPS, while navigating supply chain and labor challenges. Nov 01, 2024
REITs
Kimco Realty Corp (KIM) Q3 2024 Earnings Call Highlights: Record Occupancy and Strong Financial Performance
Kimco Realty Corp (KIM) reports a record high occupancy rate and raises full-year FFO guidance amid robust leasing activity and strategic acquisitions. Nov 01, 2024
Healthcare Plans
The Cigna Group (CI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Initiatives Propel Future Prospects
The Cigna Group (CI) reports robust third-quarter results with $63.7 billion in revenue and strategic advancements in biosimilars and share repurchases. Nov 01, 2024
Capital Markets
Intercontinental Exchange Inc (ICE) Q3 2024 Earnings Call Highlights: Record Revenues and Strategic Growth
Intercontinental Exchange Inc (ICE) reports record third-quarter revenues and significant growth across key segments, while addressing challenges in the mortgage technology sector. Nov 01, 2024
Medical Diagnostics & Research
IDEXX Laboratories Inc (IDXX) Q3 2024 Earnings Call Highlights: Strong EPS Growth Amid Market Challenges
IDEXX Laboratories Inc (IDXX) reports robust earnings growth with a focus on innovation, despite facing macroeconomic pressures and sector headwinds. Nov 01, 2024
Telecommunication Services
Comcast Corp (CMCSA) Q3 2024 Earnings Call Highlights: Revenue Boosted by Olympics, Challenges in Broadband and Theme Parks
Comcast Corp (CMCSA) reports a 6.5% revenue increase driven by the Paris Olympics, while facing profitability pressures and subscriber losses. Nov 01, 2024
Biotechnology
Regeneron Pharmaceuticals Inc (REGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Competitive Challenges
Regeneron Pharmaceuticals Inc (REGN) reports an 11% revenue increase, driven by DUPIXENT and EYLEA, while navigating pricing pressures and biosimilar competition. Nov 01, 2024
Industrial Products
AMETEK Inc (AME) Q3 2024 Earnings Call Highlights: Strong Performance Amidst Organic Sales Challenges
AMETEK Inc (AME) reports robust earnings growth and strategic acquisitions, despite facing headwinds in organic sales and increased interest expenses. Nov 01, 2024
Software
Uber Technologies Inc (UBER) Q3 2024 Earnings Call Highlights: Record Profits and Robust Growth Amid Rising Costs
Uber Technologies Inc (UBER) achieves all-time high operating profits and significant membership growth, while navigating insurance cost challenges. Nov 01, 2024
Vehicles & Parts
Aptiv PLC (APTV) Q3 2024 Earnings Call Highlights: Record EPS Amid Revenue Decline
Aptiv PLC (APTV) reports a record quarterly EPS despite a 6% revenue drop, driven by strong operating performance and strategic cost management. Nov 01, 2024
Medical Devices & Instruments
Teleflex Inc (TFX) Q3 2024 Earnings Call Highlights: Navigating Growth and Challenges
Teleflex Inc (TFX) reports a 2.4% revenue increase amidst OEM and UroLift headwinds, while raising guidance for Palette Life Sciences. Nov 01, 2024
Drug Manufacturers
Bristol-Myers Squibb Co (BMY) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic Investments Propel Future Prospects
With a 20% increase in growth portfolio revenue and strategic cost savings, Bristol-Myers Squibb Co (BMY) raises its full-year guidance amidst competitive challenges. Nov 01, 2024
Insurance
Aflac Inc (AFL) Q3 2024 Earnings Call Highlights: Strong Adjusted EPS Growth Amid Foreign Exchange Challenges
Aflac Inc (AFL) reports a 17.4% increase in adjusted EPS and robust sales growth in Japan, despite GAAP losses from foreign exchange impacts. Nov 01, 2024
Insurance
Everest Group Ltd (EG) Q3 2024 Earnings Call Highlights: Strong Returns Amid Catastrophe Challenges
Everest Group Ltd (EG) showcases robust financial performance with impressive shareholder returns, despite facing significant catastrophe losses. Nov 01, 2024
Media - Diversified
Robert Olstein's Strategic Moves in Q3 2024: A Closer Look at ABM Industries
Oct 31, 2024
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers